DOI: 10.1001/jama.2024.18080
Among Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieved better blood pressure lowering and control with good tolerability compared with the standard-care protocol, according to the VERONICA (deliVERy of Optimal blood pressure coNtrol in afrICA) trial – the first trial to evaluate a low-dose triple combination pill as initial or early therapy for hypertension in Africa. Led by Professor Dike Ojji at University of Abuja and Dr. Abdul Salam from the George Institute India, the trial was funded by the National Health and Medical Research Council (NHMRC) of Australia, supported by The George Institute for Global Health and medicine was supplied by George Medicines.
